LGRCX
Price
$21.84
Change
+$0.01 (+0.05%)
Updated
Dec 20 closing price
RGEBX
Price
$72.22
Change
+$0.65 (+0.91%)
Updated
Dec 20 closing price
Ad is loading...

LGRCX vs RGEBX

Header iconLGRCX vs RGEBX Comparison
Open Charts LGRCX vs RGEBXBanner chart's image
Loomis Sayles Growth C
Price$21.84
Change+$0.01 (+0.05%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R2E
Price$72.22
Change+$0.65 (+0.91%)
VolumeN/A
CapitalizationN/A
LGRCX vs RGEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LGRCX vs. RGEBX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGRCX is a StrongBuy and RGEBX is a Buy.

FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 301B vs. LGRCX (15.8B). RGEBX pays higher dividends than LGRCX: RGEBX (0.16) vs LGRCX (0.00). LGRCX was incepted earlier than RGEBX: LGRCX (21 years) vs RGEBX (10 years). RGEBX is a more actively managed with annual turnover of: 31.00 vs. LGRCX (13.00). RGEBX has a lower initial minimum investment than LGRCX: RGEBX (250) vs LGRCX (2500). LGRCX annual gain was more profitable for investors over the last year : 25.23 vs. RGEBX (19.08). RGEBX return over 5 years is better than : 44.55 vs. LGRCX (40.99).
LGRCXRGEBXLGRCX / RGEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years10 years-
Gain YTD25.08618.666134%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets15.8B301B5%
Annual Yield % from dividends0.000.16-
Returns for 1 year25.2319.08132%
Returns for 3 years-2.282.62-87%
Returns for 5 years40.9944.5592%
Returns for 10 years133.5869.24193%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PL4.040.16
+4.12%
Planet Labs PBC
FIVN42.631.15
+2.77%
Five9
VEEV224.154.48
+2.04%
Veeva Systems
PRQR2.630.04
+1.54%
ProQR Therapeutics NV
BIVI1.90-0.18
-8.65%
BioVie Inc